Latest News of LGND
The past three years for Ligand Pharmaceuticals (NASDAQ:LGND) investors has not been profitable
By Yahoo! Finance |
4 months ago
Ligand Pharmaceuticals' stock has increased by 10% in the last quarter, yet it has fallen 38% over the past three years, not meeting market returns. Despite EPS growth, revenue decline suggests a need...